Showcase Your Research
Applications are now open for this year's poster session. The Scientific Poster Session is designed to facilitate meaningful conversations between the scientists, clinicians, translational researchers, and drug developers advancing the next generation of rare epilepsy therapies. Share your latest findings, gain feedback from industry leaders, and engage directly with organizations developing ASOs, gene therapies, RNA medicines, precision therapeutics, and novel anti-seizure approaches.
- Demonstrate your thought leadership in rare epilepsy and DEE drug development
- Gain visibility among senior biopharma stakeholders evaluating emerging science and technologies
- Receive direct feedback from peers advancing similar therapeutic approaches
- Establish new collaborations and partnerships with decision-makers across the development ecosystem
How to Submit Your Poster
- You must first register to attend the Rare Epilepsy & DEE Drug Development Summit
- Submit an abstract for review to showcase your poster during the Scientific Poster Session
- You will be notified once your abstract has been accepted along with details of printing and size requirements. We do request an online PDF of the poster 2 weeks prior to the summit
- Scientific Poster Session: March 17, 2027
- Abstract Submission Deadline: February 19, 2027
Click the 'Submit Your Poster' button below.
Please note, there is no additional charge, but you must be attending the conference to submit an abstract. Posters should not be used for sales and marketing purposes. All abstracts are subject to approval by the conference organizers, who reserve the right to reject submissions.
Explore the Full Event Guide
- 18+ expert speakers from leading rare epilepsy innovators
- 2 interactive workshops dedicated to translational models and clinical trial optimization
- 3 panel & roundtable discussions tackling the field's biggest challenges
- 60+ senior biopharma leaders across R&D, clinical, translational and executive functions
- Dedicated coverage of ASOs, gene therapies, RNA medicines & precision small molecules
